Intensity-Modulated Radiation Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy Study of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Condition: Oral Mucositis Interventions: Drug: RRx-001; Radiation: Intensity Modulated Radiation Therapy (IMRT); Drug: Cisplatin for injection 100 mg/m2 Sponsor: EpicentRx, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients
Conditions: Esophageal Cancer; Intensity-modulated Radiation Therapy; Concurrent Chemoradiotherapy; Thrombocytopenia Intervention: Drug: rhTPO Sponsors: JIANYANG WANG; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
Phase II Study of Exclusive Intensity Modulated Radiation Therapy (IMRT) in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Condition: Tumor, Solid Interventions: Radiation: RCMI in painting dose on histoscannographic mapping; Radiation: Standard pan-sinusal IMRT Sponsor: Centre Francois Baclesse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients
Conditions: Esophageal Cancer; Intensity-modulated Radiation Therapy; Concurrent Chemoradiotherapy; Thrombocytopenia Intervention: Drug: rhTPO Sponsors: JIANYANG WANG; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
Phase II Study of Exclusive Intensity Modulated Radiation Therapy (IMRT) in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Condition: Tumor, Solid Interventions: Radiation: RCMI in painting dose on histoscannographic mapping; Radiation: Standard pan-sinusal IMRT Sponsor: Centre Francois Baclesse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients
Conditions: Esophageal Cancer; Intensity-modulated Radiation Therapy; Concurrent Chemoradiotherapy; Thrombocytopenia Intervention: Drug: rhTPO Sponsors: JIANYANG WANG; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
Phase II Study of Exclusive Intensity Modulated Radiation Therapy (IMRT) in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Condition: Tumor, Solid Interventions: Radiation: RCMI in painting dose on histoscannographic mapping; Radiation: Standard pan-sinusal IMRT Sponsor: Centre Francois Baclesse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients
Conditions: Esophageal Cancer; Intensity-modulated Radiation Therapy; Concurrent Chemoradiotherapy; Thrombocytopenia Intervention: Drug: rhTPO Sponsors: JIANYANG WANG; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
